[Specific amplification of plasma exosome miRNA in cancer patients for construction of cDNA library]

Na Wang1, Fei He1, Hongwei Yu1

  • 1College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China.

Insights

This study addresses unspecific amplification in plasma exosome microRNA (miRNA) cDNA library construction. A magnetic bead separation method effectively prevents this issue, enabling successful library creation for cancer research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • Plasma exosome microRNAs (miRNAs) are crucial biomarkers for cancer occurrence, diagnosis, and treatment.
  • The molecular mechanisms linking exosome miRNAs to cancer are not fully understood.
  • Unspecific amplification during cDNA library construction hinders accurate miRNA analysis.

Purpose of the Study:

  • To investigate and resolve the problem of unspecific amplification in plasma exosome miRNA cDNA library construction.
  • To compare enzymatic degradation with magnetic bead separation for eliminating unwanted amplification.

Main Methods:

  • Investigated enzymatic degradation using exonuclease T (EXOT) and phi29 DNA polymerase.
  • Developed and tested a magnetic bead separation method to isolate templates and primers.
  • Utilized agarose gel electrophoresis, polyacrylamide gel electrophoresis, and RT-qPCR to assess separation efficiency and miRNA levels.

Main Results:

  • Identified USR5SR as the source of unspecific amplification.
  • Enzymatic degradation degraded USR5SR but also degraded target templates.
  • Optimized magnetic bead separation using specific polyethylene glycol (PEG) concentrations for primer and template precipitation.

Conclusions:

  • The magnetic bead separation method successfully prevents unspecific amplification in plasma exosome miRNA cDNA library construction.
  • This method facilitates the successful creation of cDNA libraries from plasma exosome miRNAs of cancer patients and cell lines.
  • Enables more reliable downstream analysis of exosome miRNA biomarkers in cancer.

Related Concept Videos